4.2 Article

Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Medicine, General & Internal

ADAMTS13 Antibody Depletion by Bortezomib in Thrombotic Thrombocytopenic Purpura

Jake Shortt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Letter Medicine, General & Internal

Antibody Depletion by Bortezomib through Blocking of Antigen Presentation

Se Jin Park et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Immunology

Proteasome Inhibition Profoundly Affects Activated Human B Cells

Arend Mulder et al.

TRANSPLANTATION (2013)

Article Surgery

Bortezomib for Acute Antibody-Mediated Rejection in Liver Transplantation

F. Paterno et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2012)

Article Hematology

Autoimmune Thrombotic Microangiopathy: Advances in Pathogenesis, Diagnosis, and Management

Han-Mou Tsai

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)

Review Pharmacology & Pharmacy

Bortezomib: A novel chemotherapeutic agent for hematologic malignancies

Kyle N. Utecht et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)

Article Hematology

Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse

Ming Jin et al.

BRITISH JOURNAL OF HAEMATOLOGY (2008)

Article Hematology

Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura

Wilmar Patino et al.

JOURNAL OF CLINICAL APHERESIS (2007)